Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-deficient mice.
about
CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitisTLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage.Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation
P2860
Serum interleukin-1 receptor antagonist is an early indicator of colitis onset in Galphai2-deficient mice.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Serum interleukin-1 receptor a ...... et in Galphai2-deficient mice.
@ast
Serum interleukin-1 receptor a ...... et in Galphai2-deficient mice.
@en
type
label
Serum interleukin-1 receptor a ...... et in Galphai2-deficient mice.
@ast
Serum interleukin-1 receptor a ...... et in Galphai2-deficient mice.
@en
prefLabel
Serum interleukin-1 receptor a ...... et in Galphai2-deficient mice.
@ast
Serum interleukin-1 receptor a ...... et in Galphai2-deficient mice.
@en
P2093
P2860
P356
P1476
Serum interleukin-1 receptor a ...... et in Galphai2-deficient mice.
@en
P2093
E Hultgren Hörnquist
M Berglund
M Bjursten
O H Hultgren
P2860
P304
P356
10.3748/WJG.V12.I4.621
P407
P577
2006-01-01T00:00:00Z